CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Study on cryptogenic chronic liver disease having elevated alkaline phosphatase levels with special reference to primary biliary cirrhosis and anti mitochondrial antibody (ama) in indian population -- A case –Control study

Author: 
K. C. Dass, Sumeet David, George Kurian, Clarence J. Samuel, Pradeep Kumarm and Sana Grace
Subject Area: 
Health Sciences
Abstract: 

Background: The anti-mitochondrial antibody (AMA) is frequently tested in cryptogenic cirrhosis (CC) with elevated alkaline phophatase (ALP) levels. Like other group of chronic liver disease of known etiology may , on the course of time, lead to decompantion , liver failure and Hepatocellular carcinoma, Cryptogenic liver disease has similar course which need to be evaluated early. Aims: To determine how frequently AMA test is positive in the above mentioned clinical situation and to identify the discriminating value of clinical features in patient who tested positive in both study groups. Setting and design: Tertiary care hospital based retro-spective case control study. Materials and Methods: This was a retrospective study where 120 patients with chronic liver disease for whom the anti mitochondrial test (AMA) was done because of a raised alkaline phosphatase (ALP) formed the population from which cases and controls were drawn. 10 patients who tested AMA positive served as cases and 20 subjects that were randomly chosen from the AMA negative group served as controls. Results: AMA was rarely positive (about 8.33%) in this group of cryptogenic chronic liver disease with high ALP values in Indian. The only discriminating investigations are a high Total Bilirubin, and activated Partial Thromboplastin Time in cases which are AMA positive. The liver biopsy of one patient having AMA negative found to have features of Primary biliary Cirrhosis in our study. Conclusion: We need to do liver biopsy in the early part of the disease to ascertain the pathogenetic mechanism of liver injury in the crypto group, because in the advanced stage we hardly find the accurate sample for histopathologic evaluation. This is not an argument for discarding the AMA test in Indians but it may throw light on the evolution of this disease.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran